2020 has been an unprecendented year bringing far-reaching impacts of the pandemic on the global economy. Meanwhile, the global biopharmaceutical industry faces uncertainty and an unprecedented set of challenges. In the post-epidemic era, what will be the new trends shaping global pharmaceutical innovation? How can social capital be combined with pharmaceutical innovation? What are some smart healthcare breakthroughs created by emerging technologies such as big data, AI, and 5G? And how will it enable the building of international and domestic public health systems? This session will discuss medical and pharmaceutical innovation, smart medical applications, and public healthcare system.




Pharmaceutical Innovation

Global pharmaceutical R&D trends and investment financing trends

Sigma Bio, Jingtai Technology

Medical Devices

Resource allocation and sharing of medical device innovation services

MGI, Liangying Medical, An Han Technology, Sothern Medical

Smart Healthcare

Building a new pattern of intelligent pharmaceutical industry in the post-epidemic era

Penguin Almond, Jingdong Health

Public Healthcare

Digital transformation of the public health system of the future

Shanghai Big Data JSC